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OBJECTIVES The purpose of this study was to determine whether contractile recovery induced by
dobutamine in dysfunctioning viable myocardium supplied by nearly occluded vessels is
related to an increase in blood flow in the absence of collaterals.
BACKGROUND Dobutamine is used to improve contractility in ventricular dysfunction during acute
myocardial infarction. However, it is unclear whether a significant increase in regional blood
flow may be involved in dobutamine effect.
METHODS Twenty patients with 5- to 10-day old anterior infarction and $90% left anterior descending
coronary artery stenosis underwent 99mTc-Sestamibi tomography (to assess myocardial
perfusion) at rest and during low dose (5 to 10 mg/kg/min) dobutamine echocardiography.
Rest echocardiography and scintigraphy were repeated .1 month after revascularization.
Nine patients had collaterals to the infarcted territory (group A), and 11 did not (group B).
RESULTS Baseline wall motion score was similar in both groups (score 15.9 6 1.3 vs. 17.4 6 2.0, p 5
NS), whereas significant changes at dobutamine and postrevascularization studies were
detected (F[2,30] 5 409.79, p , 0.0001). Wall motion score improved significantly (p ,
0.001) in group A both at dobutamine (25.3 6 2.2) and at postrevascularization study
(25.5 6 1.9), as well as in group B (23.9 6 2.8 and 24.5 6 2.4, respectively). Baseline
99mTc-Sestamibi uptake was similar in both groups (62.9 6 9.7% vs. 60.3 6 10.4%, p 5 NS),
whereas at dobutamine and postrevascularization studies a significant change (F[2,30] 5
65.17, p , 0.0001) and interaction between the two groups (F[2,30] 5 33.14, p , 0.0001)
were present. Tracer uptake increased significantly in group A both at dobutamine (110.9 6
7.9%, p , 0.001) and at postrevascularization study (12.1 6 8.7%, p , 0.001). Conversely,
group B patients showed no change in tracer uptake after dobutamine test (20.4 6 5.8, p 5
NS), but only after revascularization (18.8 6 7.2%, p , 0.001).
CONCLUSIONS The increase in contractility induced by low dose dobutamine infusion in dysfunctional viable
myocardium supplied by nearly occluded vessels occurs even in the absence of a significant
increase in blood flow. (J Am Coll Cardiol 1999;33:697–704) © 1999 by the American
College of Cardiology
The inotropic agent dobutamine has been used by our group
and by others to assess viability in poorly contracting
myocardium (1–6). However, it is unclear whether a sig-
nificant increase in regional blood flow in the area supplied
by a critically narrowed coronary artery may be a component
of dobutamine-induced recovery of contractile function (7).
Evidence has been provided in the animal model (8,9)
that dobutamine infusion improves contractility without
increasing subendocardial blood flow in severely hypoper-
fused myocardium, and clinical studies have shown that
See page 705
dobutamine may ameliorate contractile dysfunction in myo-
cardium supplied by stenotic coronary arteries, in spite of a
decreased perfusion in the same regions (10).
Some authors emphasized the role of collaterals in protect-
ing ischemic myocardium and in limiting infarct size
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(11–13), although previous studies failed to detect a rela-
tionship between the presence of collaterals and myocardial
viability (14).
We hypothesized that collateral blood flow in asynergic
regions subtended by occluded or severely narrowed coro-
nary arteries could play a role in increasing perfusion during
dobutamine-induced inotropic improvement of dysfunc-
tional but viable myocardium. As dobutamine administra-
tion is known to improve contractility during the acute
phase of myocardial infarction (MI), without extension of
the ischemic injury (15–17), a prospective study was under-
taken to determine the relation between regional myocardial
perfusion and viability during low dose dobutamine (LDD)
infusion, in patients with left ventricular (LV) dysfunction
after recent MI, with and without angiographic evidence of
collaterals. The pattern of myocardial blood flow changes
was analyzed through 99mTc-Sestamibi uptake, known to
closely parallel changes in myocardial blood flow over a wide
range of flows (18). Postrevascularization echocardiographic
and single-photon emission computed tomography
(SPECT) studies were used as a reference.
METHODS
Patients and protocol. Among patients referred to our
Institution because of acute MI, 20 patients, 18 men and
two women, aged 39 to 73 years (mean 56 6 12) were
selected, since they fulfilled the following inclusion criteria:
1) recent (5 to 10 days old) anterior MI, documented by
electrocardiogram (ECG) and enzyme changes, with resid-
ual regional LV dysfunction, as documented by echocardi-
ography and angiography; 2) severe ($90% cross-sectional)
left anterior descending artery (LAD) stenosis; 3) absence of
significant stenoses in coronary arteries providing collateral
filling; 4) no evidence of previous MI at the inferior,
posterior or lateral wall; 5) absence of symptomatic conges-
tive heart failure or other significant complications during
hospitalization, and 6) revascularization procedure per-
formed during hospitalization. Thirteen patients had re-
ceived thrombolytic therapy. Seventeen patients developed
Q waves in at least two precordial leads, whereas the
remaining three patients showed non–Q wave MI.
Two-dimensional echocardiography and SPECT were
performed within 8 days after MI, at baseline, during LDD
infusion carried out 3 h later and 40 6 10 days after
revascularization. This sequence of imaging testing was
approved by the Hospital Human Rights Committee. In-
formed consent was obtained from each patient.
Cardiac catheterization. Selective coronary angiography
and biplane LV angiography were performed in all patients
within 10 days after MI and within 1 to 2 days of LDD
study. Two blinded observers evaluated the degree of
coronary lesions and the extent of visible collaterals, which
were graded according to the guidelines recommended by
the Thrombolysis in Myocardial Infarction trial classifica-
tion (12,14). Only well developed collateral flow with
visualization and dense opacification of the entire distal
vessel (grade 3) was taken into account.
Data acquisition. Echocardiography was performed after a
2-day washout period of nitrates, and beta-adrenergic and
calcium-channel blocking agents, using a 2.5-MHz trans-
ducer and a commercially available scanner (Hewlett-
Packard Sonos 1000). Images were recorded on VHS
videotape. Parasternal long-axis, parasternal short-axis (at
basal, middle and apical levels) and apical four- and two-
chamber views were used. Images were digitized on-line in
a quad screen cine loop format (Pre-Vue III, Nova Mi-
crosonics), and used to evaluate the inotropic response and
the correct timing of tracer injection.
Low dose dobutamine study was carried out at the
infusion rate of 5 mg/kg/min for 5 min, and increased to
10 mg/kg/min for another 5 min if no response in wall
motion and systolic thickening was noted with the first
dose. Recording of images as well as tracer injection were
carried out at the end of the last step of dobutamine
infusion, which was continued at the same flow rate for
3 min further after tracer injection during its distribution to
the myocardium. Blood pressure and 12-lead ECG were
monitored throughout the study. To avoid misinterpreta-
tion (19), improvements occurring within 1 cm of the
boundary of the involved myocardium were not taken into
account.
For baseline radionuclide study, 370 MBq (10 mCi) of
99mTc-Sestamibi was administered intravenously, and the
patient encouraged to have a fatty meal, to speed up
hepatobiliary elimination of the tracer. Ninety minutes later,
SPECT imaging was performed using a single-head gamma
camera (Starcam 2000, General Electric, Herts, England),
centered on the 99mTc 140-keV photopeak and equipped
with a high resolution collimator. Data were recorded in a
64 3 64 matrix across a 180° circular orbit, starting at 45°
right anterior oblique position, acquiring 32 views lasting
20 s each. Three hours after the first tracer injection, LDD
study was carried out, and 1,110 MBq (30 mCi) of the
tracer was administered in the same way as described above.
Single-photon emission computed tomography imaging
was carried out 1 h later using the same protocol as for
baseline study. Postrevascularization SPECT was carried
out under resting conditions with a dose of 370 MBq
(10 mCi) of 99mTc-Sestamibi, using the same protocol as
Abbreviations and Acronyms
ECG 5 electrocardiogram
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for baseline study. From raw radionuclide data, short-axis,
vertical long-axis and horizontal long-axis tomograms were
reconstructed by filtered back-projection using a Butter-
worth filter with a cutoff of 0.4 cycles/min, an order of 3.5
and no attenuation correction. For each set of images,
3-pixel thick slices were reconstructed along each axis, to
incorporate a substantial amount of myocardium in each
territory, as well as to optimize alignment with echocardio-
graphic segments.
Data analysis. Echocardiographic images were analyzed
off-line by two independent observers, unaware of angio-
graphic and SPECT results. The LAD territory was divided
into nine segments: anteroseptal, anterior and anterolateral,
at the chordal, midpapillary muscle and apical levels. Wall
motion and systolic thickening were graded semiquantita-
tively using a scoring system as follows: 1 5 normal wall
thickening; 2 5 hypokinesia; 3 5 akinesia; 4 5 dyskinesia.
A score $2 in at least two different views was considered
suggestive of regional systolic dysfunction, whereas im-
provement of contractile function was defined when a score
change #1 occurred.
Single-photon emission computed tomography analysis
was performed by two investigators who were blinded to
angiographic and echocardiographic results. The LAD ter-
ritory was divided into nine sectors representing the antero-
septal, anterior, anterolateral and apical wall. Each sector
was qualitatively scored on a 3-point scale: 0 5 absent or
markedly reduced activity; 1 5 definitely reduced activity;
and 2 5 normal activity. Quantitative evaluation of SPECT
images was also performed on the representative slices on
each axis by means of a computer-assisted circumferential
profile analysis (20,21). Each profile was plotted using 20
points, and the activity within each angular sector (18°) was
calculated as a percentage of total heart counts and com-
pared with 99mTc-Sestamibi reference profiles obtained at
our laboratory from a gender-specific database composed of
healthy volunteers imaged with 99mTc-Sestamibi at rest and
exercise. An uptake $2 SD below normal (always ,80%
peak activity) was considered an abnormal vascular territory.
Both dobutamine and postrevascularization improvement
were defined as an increment in 99mTc-Sestamibi uptake
.12% (i.e., .1 SD above the average uptake value observed
in normal volunteers), as compared with baseline. Abnormal
uptake was classified as mild to moderate when 99mTc-
Sestamibi activity was $50% of maximal activity, and severe
when tracer activity was ,50%.
Interobserver and intraobserver variability. Data were
checked for interobserver reproducibility by randomly se-
lecting 10 patient studies for reinterpretation by a second
investigator, and comparing the results with the initial
determinations. The agreement was good for both echocar-
diographic (r 5 0.93, p , 0.001) and SPECT data (r 5
0.92, p , 0.001). Intraobserver variability was assessed by
having the initial operator reanalyze 10 randomly selected
patient studies on a different occasion. The agreement
between the two analyses was also good for both echocar-
diographic (r 5 0.95, p , 0.001) and SPECT data (r 5
0.96, p , 0.001).
Statistical analysis. After intrapatient normalization, ordi-
nal data were expressed in percentages, and were compared
by means of chi-square test. Quantitative data are presented
as mean value 6 1 SD. To evaluate the effect of collateral
circulation on contractile response after i) LDD infusion,
and ii) myocardial revascularization, echocardiographic and
scintigraphic data were analyzed by means of analysis of
variance with repeated measures, with collateral circulation
(yes vs. no) as between-subject factor, and time of echocar-
diographic and scintigraphic evaluation (at baseline, during
LDD infusion and after revascularization) as repeated mea-
sure factor. Multiple comparisons were performed by ap-
plying the appropriate t test with Bonferroni’s correction.
The analysis was performed by using BMDP statistical
software. A p value ,0.05 was considered statistically
significant.
RESULTS
Angiographic and revascularization data. In all patients
the coronary lesion was located at the proximal LAD artery,
and was always graded $90% (total occlusion in five
patients). In seven patients the apical segment was supplied
by the right coronary artery, which in no case showed a
significant obstruction. Left ventricular ejection fraction was
$40% in 17 patients, and #25% in the others.
Based on the presence or the absence of collateral filling,
patients were divided into group A (nine patients) and
group B (11 patients), respectively. No significant difference
in age, gender, prevalence of diabetes, hypertension, ciga-
rette smoking, angina or extent of coronary artery disease
was present between the two groups.
Coronary revascularization was accomplished within 20
days of MI by coronary angioplasty in 12 patients (six
patients from each group), and by coronary artery bypass
grafting in eight (three from group A, five from group B).
Echocardiographic results. During LDD infusion, nei-
ther significant changes in heart rate or systolic blood
pressure, nor arrhythmias or ST-T changes occurred. Anal-
ysis of variance with repeated measures applied to echocar-
diographic data showed no significant difference in wall
motion score (WMS) between the two groups (main effect
of grouping factor F[1,15] 5 0.52, p 5 NS). On the
contrary, a significant difference was observed among base-
line, LDD and postrevascularization study (main effect of
repeated measures F[2,30] 5 409.79, p , 0.0001). This
difference was not affected by the presence or absence of
collaterals (interaction F[2,30] 5 1.41, p 5 NS) (Table 1).
Multiple comparisons performed by two-group t test with
Bonferroni’s correction showed no significant difference in
WMS between the two groups at baseline, LDD and
postrevascularization study (p 5 NS).
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Paired t test with Bonferroni’s correction showed a
significant improvement of WMS in both groups, compar-
ing LDD study (group A: 25.3 6 2.2, p , 0.001; group B:
23.9 6 2.8, p , 0.001) as well as postrevascularization
study (group A: 25.5 6 1.9, p , 0.001, group B: 24.5 6
2.4, p , 0.001) to baseline values (Fig. 1 to 3).
Radionuclide results. Analysis of variance with repeated
measures applied to scintigraphic data showed no significant
difference in average tracer uptake between the two groups
(main effect of grouping factor F[1,15] 5 1.38, p 5 NS).
On the contrary, a significant difference was observed
among baseline, LDD and postrevascularization study
(main effect of repeated measures F[2,30] 5 65.17, p ,
0.0001); this difference was affected by the presence or
absence of collaterals (interaction F[2,30] 5 33.14, p ,
0.0001) (Table 1).
Multiple comparisons performed by two-group t test with
Bonferroni’s correction showed no difference in quantitative
SPECT analysis between the two groups at baseline, LDD
and postrevascularization study (p 5 NS).
Paired t test with Bonferroni’s correction showed an
increase of tracer uptake both at LDD study (110.9 6
7.9%, p , 0.0001) and after revascularization (112.1 6
8.7%, p , 0.001) in comparison with baseline values in
group A. Conversely, in group B, tracer uptake slightly but
not significantly decreased at LDD study (20.4 6 5.8%,
p 5 NS), and improved significantly after revascularization
(18.8 6 7.2%, p , 0.001) in comparison with baseline
values (Fig. 1 to 3).
A significant difference in tracer uptake was found in
group B patients when comparing postrevascularization
with LDD study results (p , 0.005).
DISCUSSION
The results of the present study confirm that hypoperfused
viable myocardium supplied by nearly occluded arteries can
increase contractility in response to LDD infusion, despite
Figure 1. Bar histograms comparing echocardiographic (top) and
scintigraphic results (bottom) at baseline, during low dose dobut-
amine infusion and postoperatively (POST-REV), in patients with
(group A) and without (group B) collaterals. The lack of significant
changes in myocardial 99mTc-Sestamibi uptake after dobutamine
infusion in patients without collaterals is clearly visible, in spite of
a recovery of both function and perfusion detected after revascu-
larization.
Table 1. Results of Analysis of Variance With Repeated Measures
Variables
Group p Values
Collateral Present
(n 5 9)
(Mean 6 SD)
Collateral Absent
(n 5 11)
(Mean 6 SD)
Main Effect of
Grouping
Factor
Main Effect of
Repeated
Measures Interaction
Echocardiography (WMS) NS , 0.0001 NS
Baseline 15.9 6 1.3 17.4 6 2.0
LDD 10.6 6 1.1 13.5 6 4.3
Postrevascularization 10.4 6 1.1 12.9 6 4.4
Scintigraphy (% uptake) NS , 0.0001 , 0.0001
Baseline 62.9 6 9.7 60.3 6 10.4
LDD 73.8 6 11.9 59.9 6 15.9
Postrevascularization 75.0 6 10.8 69.1 6 11.9
LDD 5 low dose dobutamine; WMS 5 wall motion score. Interaction refers to comparisons between baseline, LDD and postrevascularization studies within group A (collaterals
present) and group B (collaterals absent) patients.
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the lack of significant improvement in regional myocardial
perfusion. Although the presence of collaterals can contrib-
ute to matching, the increased oxygen demand induced by
LDD infusion in territories distal to a severe coronary
stenosis, their presence does not seem to be necessary for the
drug to be effective. Thus, in the absence of angiographically
visible collaterals, such a phenomenon may lead to an
apparent mismatch between increased contractility and
almost unchanged relative myocardial blood flow.
Previous investigations. Intracoronary infusion of dobut-
amine in the animal resulted in an increase of maximum
work of hypoperfused myocardium without altering global
hemodynamics, even in the presence of decreased subendo-
cardial blood flow (8,9). An improvement of myocardial
blood flow distal to an induced coronary stenosis, in
response to dobutamine infusion, was also described (22).
However, coronary perfusion pressure was deliberately held
constant in the latter study, thus not adequately representing
the clinical setting, in which dobutamine-induced arteriolar
vasodilation can result in a reduction of perfusion pressure
distal to a coronary lesion, with a further possible reduction
of subendocardial blood flow.
A correlation between function and perfusion with do-
butamine infusion in the clinical setting was reported by
Coma-Canella et al., who found an increase in regional
contractility only when dobutamine induced a mild to
moderate ischemia, whereas the contractile function was
worsened with severe ischemia (10).
Additional investigation recently supported the concept
that different patterns of baseline perfusion, as well as of
perfusional changes during LDD infusion, are possible in
dysfunctioning yet viable myocardium (7). No significant
correlation between myocardial blood flow and WMS, both
at rest and during dobutamine infusion, was observed in
different types of dysfunctioning myocardium. Wall motion
Figure 2. Example of echocardiographic and scintigraphic images obtained in a patient with collaterals (group A) at baseline, during low
dose dobutamine infusion and after revascularization (POST-REV). In the top row, a left ventricular end-systolic frame obtained at
echocardiographic study in the four-chamber view is shown. In the bottom row, a set of tomographic slices reconstructed along the short
axis from left ventricular apex to base (a3d) is shown. The decrease in left ventricular end-systolic dimensions at both dobutamine and
postrevascularization echocardiographic studies in comparison with the basal study is visible. The functional changes were associated with
an increase in 99mTc-Sestamibi uptake detected at dobutamine scan in the areas of the previous infarction in comparison with basal scan,
and confirmed after revascularization.
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improvement was not consistently associated with an in-
crease in myocardial blood flow and vice versa. Similarly,
Lee et al. showed contractile reserve to be only in part
dependent on the level of myocardial blood flow at rest and
during inotropic stimulation in a mixed patient population
with and without previous MI (23). Though the presence
and the functional efficacy of collateral filling was not
specifically addressed in these studies, possibly a variable
prevalence of collaterals was at least in part responsible for
the inconsistency of the results obtained.
Elhendy et al. recently showed that the presence of
collaterals failed to identify a different behavior of viable
myocardial areas at both LDD echocardiography and after
revascularization (24), although without evaluating myocar-
dial blood flow, either invasively or noninvasively. However,
previous investigations by Di Carli et al. had already shown
the lack of correlation between myocardial viability assessed
by means of positron emission tomography (PET) and the
presence of collaterals (14).
Pathophysiologic explanations. A body of experimental
data demonstrated that distal to critical coronary stenoses
the subendocardial vasodilator reserve is exhausted (25–27).
In such a condition, a further reduction of perfusion
pressure, induced either pharmacologically (28,29) or
through metabolic vasodilation (30,31), results in an uneven
distribution of myocardial blood flow, which is improved in
the subepicardial layers, and unchanged or paradoxically
reduced in subendocardial areas.
As shown by the results of the present report, the
majority of 99mTc-Sestamibi defects observed at baseline in
patients with collaterals filled in when the tracer was
injected during recovery of contractility. In the presence of
an exhausted flow reserve, this would imply that collaterals
improve blood flow distal to the coronary stenosis, in
response to the increased oxygen demand induced by LDD
administration in hypoperfused myocardium. Conversely, in
patients without collaterals, a mismatch between improved
contractility and unchanged 99mTc-Sestamibi activity was
Figure 3. Example of echocardiographic and scintigraphic images obtained in a patient without collaterals (group B) at baseline, during
low dose dobutamine infusion and after revascularization (POST-REV) (image composed as in Fig. 2). The decrease in left ventricular
end-systolic dimensions at both dobutamine and postrevascularization echocardiographic studies in comparison with the basal study is
visible. Differently from the patient shown in Figure 2 (a patient with collaterals), no change in 99mTc-Sestamibi uptake in the infarcted
area is visible at dobutamine scan in comparison with basal scan. A significant increase in tracer uptake was nevertheless detected after
revascularization.
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evident. Thus, it appears reasonable to argue that an
increase in regional blood flow is not involved in the
recovery of contractile function induced by LDD. Indeed, in
the presence of an inhomogeneous increase of flow induced
by LDD, a coronary steal could have been responsible for
ischemia, as observed by Mayer et al. (32). Also, more
recently, a flow redistribution from the subendocardium
toward the subepicardium as a consequence of intracoronary
dobutamine infusion has been reported in animal investiga-
tions (9,33).
The results obtained in the present study after revascu-
larization demonstrate that in patients without collaterals
the lack of improvement of tracer activity in territories
susceptible to contractile recovery does not necessarily imply
irreversible myocardial damage. Indeed, in these patients
the majority of segments identified as viable at echocardi-
ography exhibited complete recovery of contractility after
revascularization, and this was coincident with a more
evident increase in 99mTc-Sestamibi uptake, as compared
with patients with collaterals, in whom the increase in tracer
uptake with LDD was similar to that achieved after revas-
cularization.
The results of the present study might apparently seem to
run counter to existing data on the diagnostic effectiveness
of LDD echocardiography and scintigraphy in the evalua-
tion of myocardial viability. However, many segments
without collaterals presented with a baseline tracer uptake
.50%, which is generally regarded as representing viable,
though hypoperfused, tissue, and were therefore viable from
a scintigraphic point of view.
Study limitations. It is conceivable that patients early after
acute MI will have continuous changes in regional myocar-
dial perfusion, LV geometry and regional wall motion.
Additionally, the development of collaterals occurs very
early after MI. Therefore, all patients underwent coronary
angiography, echocardiography and scintigraphy within a
few days, and 99mTc-Sestamibi SPECT was performed as a
single-day protocol (34–36).
It is possible that the absolute amount of activity in a
segment was related to improvement of contractile function
with dobutamine, rather than to increased blood flow, such
as described by others (20,37). However, dobutamine effects
on wall motion and thickening are very short-lasting, and
were certainly over at the time of imaging. Additionally,
improved wall motion was observed to the same extent both
in the presence and in the absence of increased tracer
uptake.
The main limitation of the present study is certainly due
to the impossibility of measuring absolute blood flow
through 99mTc-Sestamibi uptake, in the absence of a quan-
titative evaluation by PET. Despite a close relation between
PET results and those obtained with Sestamibi as well as
201Tl (38), a possible increase in blood flow to infarcted
areas, although to a lesser extent than in normally perfused
areas, in response to LDD infusion cannot be excluded.
However, as the increase in tracer uptake induced by LDD
in normal areas was presumably similar in both groups, the
lower tracer uptake in areas not supplied by collaterals
should reflect a truly different behavior. In any case, such a
wide difference in the pattern of relative tracer uptake
between collateral-dependent and -independent areas can
hardly be related to similar dobutamine effectiveness.
Conclusions. The present study gives some insights into
the role played by collateral circulation in the flow response
to inotropic stimulation, in the presence of critically nar-
rowed epicardial coronary arteries and consequently of
almost exhausted precapillary flow reserve. Certainly, the
interplay between anterograde and retrograde filling and the
increase in myocardial oxygen demand induced by dobut-
amine infusion has still to be clarified. Furthermore, the
evidence of a mismatch between functional improvement
induced by inotropic agents and relatively unchanged myo-
cardial blood flow in acute ischemic heart failure warrants
further clinical investigations.
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